Efficacy and safety of daily supplementation with PMG151 in individuals living with Human Immunodeficiency Virus (HIV)

Completed

• Conditions: AIDS/HIV; Infections and Infestations; Human immunodeficiency virus [HIV] disease

• Registration Number: ISRCTN22931534
• Lead Sponsor: Centre for Traditional Medicine and Integrated Care (Centre de Medecine Traditionelle et de Soins integrés [CMTSI]) (Burkina Fas

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-09-15
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 186

Inclusion Criteria

1. HIV1 seropositive persons
2. Age between 18-55 years
3. Written informed consent given
4. Live in the study area for 12 next months

Exclusion Criteria

1. Pregnant and/or lactating females
2. HIV2 seropositive or HIV1 and HIV2 coinfection
3. High blood pressure (Hypertension)
4. Cardiac or renal disease
5. History of known sickle cell disease
6. Alcohol abuse

Study & Design

• Study Type: Interventional
• Study Design: Not specified